Company intelligence / Profile preview

Envoya

Boston, Massachusetts, United Statesenvoyabio.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Envoya has developed a proprietary biopolymer-nanoparticle/AI-based drug delivery platform that addresses key limitations of current gene therapy vectors. The company reports up to four times higher DNA encapsulation yield compared to lipid nanoparticles without compromising efficiency. Early preclinical data show promise in multiple oncology models and rare genetic disease settings. No clinical-stage programs have been announced yet.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Gene therapies (including siRNA/shRNA, pDNA, mRNA/microRNA, CRISPR)Nucleic acidsBiopolymer-nanoparticles for drug delivery
Industry: Biotech

Partnerships

Actively seeking partnerships with pharmaceutical companies and research institutions but no major deals publicly announced yet.The company emphasizes collaboration opportunities for co-developing customized solutions using their proprietary systems.

Beyond the preview

Go deeper on Envoya.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Envoya.

Explore the full profile